US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 1.090
  • -0.030-2.68%
Close Mar 18 16:00 ET
143.89MMarket Cap-0.34P/E (TTM)

About RAPT Therapeutics Company

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolRAPT
Company NameRAPT Therapeutics
Listing DateOct 31, 2019
Issue Price12.00
Founded2015
CEODr. Brian Russell Wong, M.D.,PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address561 Eccles Avenue
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-489-9000
Websitehttp://rapt.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian Russell Wong, M.D.,PhD
  • President, Chief Executive Officer and Director
  • 6.59M
  • Rodney Young
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • 2.18M
  • Dr. Dirk G. Brockstedt, PhD
  • Chief Scientific Officer
  • --
  • Dr. William Ho, M.D.,PhD
  • Chief Medical Officer
  • 1.90M
  • Lori Lyons-Williams
  • Chairman of the Board
  • 262.28K
  • Linda Kozick
  • Independent Director
  • 260.78K
  • Dr. Michael F. Giordano, M.D.
  • Independent Director
  • 267.78K
  • Dr. Wendye Robbins, M.D.
  • Independent Director
  • 265.28K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 277.78K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Dorian LPG
LPG
22.520
YETI Holdings
YETI
34.180
Workday
WDAY
251.910
4
Collegium Pharmaceutical
COLL
29.820
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.010
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!